Chemical modification of collagen improves glycosaminoglycan retention of their co-precipitates
Source abstract
Abstract
Being prevalent extracellular matrix components, collagen and glycosaminoglycan (GAG) are co-precipitated as scaffolds for tissue regeneration. However, the amount of GAG incorporated and its long-term retention present a persistent problem. In this study, chemical modifications, namely deamination, methylation and amination, were used to alter the net charge of collagen prior to fabrication of collagen-GAG co-precipitate. While most GAGs were lost in the untreated group and the deaminated group within 1 day, methylation and amination of collagen retained over 20% and 40% GAG after 6 days, respectively. Moreover, over 60% of GAG retention was achieved in the aminated group after cell seeding for 8 days. Furthermore, amination of collagen increased the GAG/hydroxyproline ratio in the co-precipitate to >4.5, approaching that of native nucleus pulposus. Ultrastructural analysis showed that the aminated group contains abundant granular substances resembling the extracellular matrix of native nucleus pulposus. Despite lower initial cell adhesion than untreated, all modified scaffolds promoted proliferation of human mesenchymal stem cells (hMSCs) and showed >95% cell viability at all time points. Cell morphology was distinct among the different groups, being round in the untreated control and methylated groups but elongated in deaminated and aminated groups. hMSCs adhered to scaffolds via collagen receptor integrin α2β1 in all groups, while all but the aminated group showed extensive expression of the general matrix receptor integrin αv. This work reports an effective method, namely amination of collagen, to improve GAG incorporation and retention in collagen-GAG co-precipitates, facilitating the fabrication of GAG-rich collagenous scaffold for intervertebral disc tissue engineering.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Spine and Intervertebral Disc Pathology · Proteoglycans and glycosaminoglycans research · Osteoarthritis Treatment and Mechanisms
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Matrix proteoglycans; from molecular design to cellular function10.1146/annurev.biochem.67.1.609 ↗
2. Proteoglycans of the extracellular matrix and growth control10.1002/jcp.10030 ↗
3. Wound tissue can utilize a polymeric template to synthesize a functional extension of skin10.1126/science.7031899 ↗
4. Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin10.1073/pnas.86.3.933 ↗
5. Biologically-active analogs of the extracellular-matrix—artificial skin and nerves10.1002/anie.199000201 ↗
6. Optimal degradation rate for collagen chambers used for regeneration of peripheral nerves over long gaps10.1159/000075035 ↗
7. A collagen-glycosaminoglycan scaffold supports adult rat mesenchymal stem cell differentiation along the osteogenic and chrondrogenic routes10.1089/ten.2006.12.459 ↗
8. The effects of collagen concentration and crosslink density on the biological, structural and mechanical properties of collagen-GAG scaffolds for bone tissue engineering10.1016/j.jmbbm.2008.08.007 ↗
9. Mechanical characterization of collagen-glycosaminoglycan scaffolds10.1016/j.actbio.2006.12.009 ↗
10. An injectable cross-linked scaffold for nucleus pulposus regeneration10.1016/j.biomaterials.2007.10.009 ↗
11. The effect of deamination and/or blocking arginine residues on the molecular assembly of acid-extracted rat tail tendon collagen10.1016/S0040-8166(96)80009-7 ↗
12. Binding of mucopolysaccharides and dyes by collagen10.1016/S0021-9258(18)56175-5 ↗
13. The chemistry of connective tissues; the state of combination of chondroitin sulphate in cartilage10.1042/bj0430387 ↗
14. The retention and ultrastructural appearances of various extracellular matrix molecules incorporated into three-dimensional hydrated collagen lattices10.1016/0012-1606(85)90461-0 ↗
15. Interaction between collagen and chondroitin-6-sulfate10.3109/03008207309152597 ↗
16. Design of an artificial skin. II. Control of chemical composition10.1002/jbm.820140203 ↗
17. In vivo and in vitro applications of collagen-GAG scaffolds10.1016/j.cej.2007.09.009 ↗
18. Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds10.1016/S0142-9612(03)00630-6 ↗
19. The effect of dehydrothermal treatment on the mechanical and structural properties of collagen-GAG scaffolds10.1002/jbm.a.31955 ↗
20. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects10.1016/S0142-9612(99)00222-7 ↗
21. Crosslinked collagen-chondroitin sulfate-hyaluronic acid imitating extracellular matrix as scaffold for dermal tissue engineering10.1089/ten.tec.2009.0161 ↗
22. Chemically modified collagen: a natural biomaterial for tissue replacement10.1002/jbm.820210606 ↗
23. Specific group reagents for proteins10.1021/cr60128a004 ↗
24. The interpretation of electron micrographs of negatively stained native collagen10.1242/jcs.10.2.547 ↗
25. Improving biomaterial properties of collagen films by chemical modification
26. Electron microscope studies of deaminated and crosslinked collagen10.1111/j.1365-2818.1970.tb02233.x ↗
27. Esterification of proteins with alcohols of low molecular weight10.1016/S0021-9258(17)41539-0 ↗
28. The amino acid composition of mammalian collagen and gelatin10.1042/bj0610589 ↗
29. Cross-linking of dermal sheep collagen using a water-soluble carbodiimide10.1016/0142-9612(96)81413-X ↗
30. Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies10.1093/glycob/cwg082 ↗
31. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid10.1016/0003-9861(61)90291-0 ↗
32. Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents10.1111/j.1365-2141.2004.05200.x ↗
33. The alpha v beta 3 integrin “vitronectin receptor”10.1016/S1357-2725(96)00155-0 ↗
34. Multiple functional forms of the integrin VLA-2 can be derived from a single alpha 2 cDNA clone: interconversion of forms induced by an anti-beta 1 antibody10.1083/jcb.120.2.537 ↗
35. Distinction between the extracellular matrix of the nucleus pulposus and hyaline cartilage: a requisite for tissue engineering of intervertebral disc10.22203/eCM.v008a06 ↗
36. The determination of hydroxyproline10.1016/S0021-9258(19)51149-8 ↗
37. The amino-acid composition and titration curve of collagen10.1042/bj0430358 ↗
38. The precipitation of segmented-long-spacing collagen by inorganic triphosphate and perdisulphate Ions10.3109/03008207209152063 ↗
39. Ultrastructure and assembly of segmental long spacing collagen studied by atomic force microscopy10.1016/S0968-4328(00)00038-X ↗
40. Electron microscopy of cartilage proteoglycans10.1007/BF01004761 ↗
41. Extracellular matrix in disc degeneration
42. The nucleus of the intervertebral disc from development to degeneration
43. Articular cartilage glycosaminoglycans inhibit the adhesion of endothelial cells10.3109/03008207.2011.629310 ↗
44. Chondroitin sulfate and heparan sulfate-containing proteoglycans are both partners and targets of basic fibroblast growth factor-mediated proliferation in human metastatic melanoma cell lines10.1016/j.biocel.2007.06.019 ↗
45. Isolation and characterization of chondroitin sulfate proteoglycans from embryonic quail that influence neural crest cell behavior10.1006/dbio.1997.8731 ↗